MedTrace Logo

Sustainable Method for Alzheimer's Prediction

NCT03654911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-07-22

No results posted yet for this study

Summary

This is an observational study with the aim of validating, in a consistent population sample, with appropriate follow-up, whether EEG connectivity analysis combined with the neuropsychological evaluation and ApoE genotype testing in aMCI could be of help in early identification of converted aMCI as a first-line screening method in order to intercept early those subjects with a high risk for rapid progression to AD.

Conditions

  • Alzheimer Disease
  • Amnestic-Mild Cognitive Impairment

Interventions

DIAGNOSTIC_TEST

EEG

EEG

GENETIC

ApoE

ApoE

Sponsors & Collaborators

  • Catholic University of the Sacred Heart

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2019-06-28
Completion
2020-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03654911 on ClinicalTrials.gov